The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts

Biotech stocks staged a steady recovery last week. ASCO presentations dominated the headlines, with Iovance Biotherapeutics Inc (NASDAQ: IOVA) and Mirati Therapeutics Inc (NASDAQ: MRTX) among the biggest gainers. The IPO calendar was empty and there were a slew of clinical trial readouts that swayed stocks.

The following are key catalysts expected in the unfolding week.